Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer
Clinical trial NCT03451162 · COMPLETED
Trial details
- NCT number
- NCT03451162
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2021-07-16
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.